Company Overview of NPS Pharmaceuticals, Inc.
NPS Pharmaceuticals, Inc., a biopharmaceutical company, provides therapeutic products for the treatment of gastrointestinal and endocrine disorders. The company offers Gattex for the treatment of adult patients with short bowel syndrome (SBS) who are dependent on parenteral support in the United States; and Revestive for the treatment of adult patients with SBS in the European Union. Its products also include Gattex/Revestive in pediatric SBS, which has completed an open-label 4-cohort study; Natpara, a bioengineered replica of human parathyroid hormone to control hypocalcemia in patients with hypoparathyroidism; and Natpar to treat hypoparathyroidism, as well as NPSP795, a calcilytic agent,...
550 Hills Drive
Bedminster, NJ 07921
Founded in 1986
Key Executives for NPS Pharmaceuticals, Inc.
Compensation as of Fiscal Year 2014.
NPS Pharmaceuticals, Inc. Key Developments
NPS Pharmaceuticals, Inc. Presents at Boston CEO Conference, May-26-2015 through May-27-2015
Apr 16 15
NPS Pharmaceuticals, Inc. Presents at Boston CEO Conference, May-26-2015 through May-27-2015. Venue: Four Seasons Hotel, 200 Boylston Street, Boston, MA 02116, United States. Presentation Date & Speakers: May-26-2015, Francois Nader. May-27-2015, Francois Nader.
NPS Pharmaceuticals Announces Board Changes
Feb 23 15
NPS Pharmaceuticals, Inc. announced that In accordance with the terms of the Merger Agreement with Shire Pharmaceutical Holdings Ireland Limited and Knight Newco 2, Inc. (Purchaser), the directors of Purchaser immediately prior to the Effective Time became the directors of the Surviving Corporation. Accordingly, each of Francois Nader, Peter G. Tombros, Michael W. Bonney, Colin Broom, Georges Gemayel, Pedro Granadillo, James G. Groninger, Pierre Legault and Rachel R. Selisker ceased serving as members of the NPS Pharmaceuticals, Inc.'s board of directors as of the Effective Time. In addition, immediately following the Effective Time, all of the officers of the company immediately prior to the Effective Time were removed and were replaced by the officers of Purchaser.
NPS Pharmaceuticals, Inc.(NasdaqGM:NPSP) dropped from NASDAQ Composite Index
Feb 23 15
NPS Pharmaceuticals, Inc. will be removed from NASDAQ Composite Index.
Similar Private Companies By Industry
Recent Private Companies Transactions
January 11, 2015